ALLMedicine™ Gastric Cancer Center
Research & Reviews 14,785 results
https://doi.org/10.1186/s12876-022-02324-8 10.1186/s12876-019-0949-5 10.1007/s10120-017-0716-7 10.1007/s10120-016-0601-9 10.1007/s10120-015-0469-0 10.3322/caac.21660 10.1016/j.jes.2019.09.025 10.1038/nature04506 10.1111/brv.12107 10.1038/nature01356 10.1093/bioinformatics/btp352 10.1101/gr.107524.110 10.1093/nar/gkq603 10.1093/bioinformatics/btq033 10.1093/bioinformatics/btr310 10.1038/srep32679 10.1016/S0097-8485(96)80004-0 10.1002/advs.201800640 10.1186/s13059-016-0989-x 10.1038/nature12912 10.1038/nature12213 10.1093/nar/gky1126 10.1038/nature13480 10.3389/fonc.2020.01033 10.1093/nar/gky1015 10.1186/s13059-015-0583-7 10.1038/nchembio.1986 10.3934/mbe.2019296
BMC Gastroenterology; Yuan L, Chen S et. al.
May 16th, 2022 - Gastric cancer, or stomach cancer, that originates in the inner lining of the stomach, was the fifth most common cancer and the fourth mortality globally, with over one million new cases in 2020 and an estimated 769,000 deaths. The molecular chara...
https://doi.org/10.1007/s00535-022-01878-4 10.3322/caac.21660 10.1002/ijc.11183 10.1038/bjc.2014.608 10.1053/j.gastro.2017.01.029 10.1245/ASO.2006.04.028 10.1002/ijc.2910600106 10.1016/S1470-2045(08)70072-X 10.1016/j.gie.2016.02.028 10.1093/jjco/hyy077 10.1136/gutjnl-2015-310356 10.4143/crt.2021.291 10.1186/1471-230X-13-104 10.4143/crt.2020.610 10.1111/hel.12463 10.4143/crt.2016.186 10.1111/apm.1965.64.1.31 10.1158/1055-9965.EPI-09-0250 10.1016/j.jval.2014.03.733 10.1002/cncr.10646 10.1371/journal.pone.0126796 10.1371/journal.pone.0079088 10.1111/cas.12829 10.1245/s10434-019-07455-z 10.1097/00042737-200512000-00013 10.1371/journal.pone.0050041 10.5946/ce.2014.47.6.490 10.1007/PL00011735 10.1097/MEG.0b013e328318ed42 10.1002/cncr.27495 10.1207/S15327914NC381_5 10.3748/wjg.15.3653 10.1186/s12885-015-1328-4 10.4143/crt.2021.482 10.1002/cncr.32753 10.3748/wjg.v16.i2.245 10.1093/annonc/mdj007 10.1016/S0959-8049(97)10098-3 10.1371/journal.pone.0089655 10.4143/crt.2016.243 10.1615/JEnvironPatholToxicolOncol.2017024821 10.5009/gnl16397 10.4143/crt.2015.264 10.1111/j.1523-5378.2011.00859.x 10.1007/978-3-319-40618-3
Journal of Gastroenterology; Luu XQ, Lee K et. al.
May 15th, 2022 - Gastric cancer (GC) is the most common cancer type in Korea. Korean National Cancer Screening Program (KNCSP) offer either upper gastrointestinal series (UGIS) or upper endoscopy biennially for adults aged ≥ 40. This study aimed to investigate the...
https://doi.org/10.3390/ijerph19095437
International Journal of Environmental Research and Publi... Cordova-Marks FM, Carson WO et. al.
May 15th, 2022 - Gastric cancer is a worldwide concern, particularly for Indigenous populations who face greater disparities in healthcare. With decreased access to screening and critical treatment delays, this group is experiencing adverse health effects. To dete...
https://doi.org/10.1186/s12885-022-09623-z 10.3322/caac.21492 10.1056/NEJMoa055531 10.1016/S0140-6736(18)32557-1 10.1016/S1470-2045(16)30531-9 10.1371/journal.pone.0189294 10.1111/j.1600-065X.2009.00767.x 10.1371/journal.pone.0131403 10.1371/journal.pone.0182692 10.1016/j.ctrv.2018.04.004 10.1016/S1470-2045(16)00175-3 10.1001/jamaoncol.2018.0013 10.1001/jamaoncol.2020.3370 10.1016/j.annonc.2020.08.2296 10.1073/pnas.0805459105 10.1136/jitc-2020-000530 10.1002/cncr.11660 10.7150/jca.31755
BMC Cancer; Dos Santos M, Lequesne J et. al.
May 14th, 2022 - Perioperative chemotherapy and surgery are a standard of care for patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, the prognosis remains poor for this population. The FLOT (fluorouracil, leucovorin, oxal...
https://doi.org/10.1186/s12876-022-02312-y 10.3322/caac.21492 10.3748/wjg.v21.i8.2460 10.1016/j.gie.2008.10.064 10.1016/j.gie.2009.03.1171 10.1055/s-2008-1077507 10.1111/den.12638 10.1053/j.gastro.2011.08.007 10.1111/den.12183 10.5009/gnl14281 10.1055/s-0042-103416 10.1155/2002/548616 10.1055/s-2004-814533 10.1038/nrgastro.2013.134 10.1111/j.1365-2036.2011.04647.x 10.1016/j.giec.2004.03.013 10.1055/s-0034-1377524 10.1055/s-0034-1393249 10.1038/s41591-018-0300-7 10.1038/s41568-018-0016-5 10.1016/S1470-2045(19)30154-8 10.1097/CM9.0000000000000623 10.1038/nature14539 10.1007/s10120-018-0793-2 10.1016/S1470-2045(19)30637-0 10.1111/jgh.12149 10.1007/s10620-019-05862-6 10.1007/s10120-019-00992-2 10.1007/s11263-019-01228-7 10.1038/bmt.2012.244 10.1007/s10120-016-0622-4 10.1016/j.gie.2014.09.008 10.1016/j.cgh.2019.09.009 10.1016/j.gie.2018.09.024 10.1007/s10388-018-0651-7 10.1016/S0016-5107(92)70567-7 10.1007/s00464-019-06686-1 10.1007/s10120-020-01125-w
BMC Gastroenterology; Noda H, Kaise M et. al.
May 14th, 2022 - Endocytoscopy (ECS) aids early gastric cancer (EGC) diagnosis by visualization of cells. However, it is difficult for non-experts to accurately diagnose EGC using ECS. In this study, we developed and evaluated a convolutional neural network (CNN)-...
Guidelines 23 results
https://doi.org/10.6004/jnccn.2022.0008
Journal of the National Comprehensive Cancer Network : JN... Ajani JA, D'Amico TA et. al.
Feb 8th, 2022 - Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor p...
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.
Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...
https://doi.org/10.6004/jnccn.2021.0001
Journal of the National Comprehensive Cancer Network : JN... Daly MB, Pal T et. al.
Jan 7th, 2021 - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.
Aug 8th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;
Nov 26th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...
Drugs 3 results see all →
Clinicaltrials.gov 565 results
https://clinicaltrials.gov/ct2/show/NCT03092518
May 13th, 2022 - Background: An estimated 24,590 cases of gastric adenocarcinoma are diagnosed annually in the U.S. The peritoneal surface is a site of metastasis found often at time of diagnosis and is a common (40%) site of recurrence. Laparoscopy with peritonea...
https://clinicaltrials.gov/ct2/show/NCT05371249
May 12th, 2022 - Helicobacter pylori infection is a well-established risk factor for peptic ulcer disease and gastric cancer. It's now a consensus of experts that H.pylori infection should be treated once it is recognized. Extended proton pump inhibitor (PPI)-base...
https://clinicaltrials.gov/ct2/show/NCT05071053
May 12th, 2022 - 34 weeks (up to 4 weeks for screening, a median of 18 weeks for treatment, and a median of 12 weeks for end-of-treatment assessments and the safety follow-up visit).
https://clinicaltrials.gov/ct2/show/NCT02065765
May 11th, 2022 - The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the compassionate use program.
https://clinicaltrials.gov/ct2/show/NCT04661150
May 9th, 2022 - This is a phase II, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of perioperative trastuzumab+XELOX with / without atezolizumab in participants eligible for surgery with locally advanced HER2-positive gast...
News 648 results
https://www.medscape.com/viewarticle/973400
May 10th, 2022 - I remember it like it was yesterday: It was my first American Society of Clinical Oncology (ASCO) Annual Meeting. I was a PGY-1 and I was presenting about gastric cancer in Hispanic individuals and the disparities that this population experiences ...
https://www.onclive.com/view/sot101-plus-pembrolizumab-elicits-encouraging-efficacy-in-advanced-solid-tumors
May 2nd, 2022 - The addition of SOT101, an interleukin (IL)-2/IL-15 Rβγ superagonist, to Pembrolizumab (Keytruda) generated a clinical benefit and encouraging safety data in patients with advanced solid tumors, according to data presented at the 2022 AACR Annual ...
https://www.onclive.com/view/fda-issues-complete-response-letter-to-toripalimab-for-nasopharyngeal-carcinoma
May 2nd, 2022 - The FDA has issued a complete response letter (CRL) to the biologics license application (BLA) seeking the approval of toripalimab for use in combination with gemcitabine and cisplatin in the frontline treatment of patients with advanced recurrent...
https://www.mdedge.com/hematology-oncology/article/254103/gastrointestinal-cancer/gastric-cancer-add-apatinib-neoadjuvant
Apr 26th, 2022 - Key clinical point: Neoadjuvant treatment with apatinib in combination with oxaliplatin and capecitabine shows good response and a manageable safety profile in patients with locally advanced adenocarcinoma of the stomach or gastroesophageal juncti.
https://www.medscape.com/viewarticle/972679
Apr 25th, 2022 - The study featured in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways APOA2 is overexpressed in gastric adenocarcinoma compared with normal gastric tissue samples. It appears to be i...
